Drug reaction with eosinophilia and systemic symptoms (DRESS) induced by imatinib in chronic myeloid leukemia.

Vatel, Orlane; Aumont, Cedric; Mathy, Vincent; Petit, Morgane; Feriel, Joffrey; Sloma, Ivan; Bennaceur-Griscelli, Annelise; Turhan, Ali G

Vatel, Orlane; Aumont, Cedric; Mathy, Vincent; Petit, Morgane; Feriel, Joffrey; Sloma, Ivan; Bennaceur-Griscelli, Annelise; Turhan, Ali G.

Affiliation

Vatel O; a Department of Hematology , Centre Hospitalier Universitaire, Université Paris Sud 11 , Le Kremlin Bicêtre , France.
Aumont C; a Department of Hematology , Centre Hospitalier Universitaire, Université Paris Sud 11 , Le Kremlin Bicêtre , France.
Mathy V; b INSERM U935 , Villejuif , France.
Petit M; a Department of Hematology , Centre Hospitalier Universitaire, Université Paris Sud 11 , Le Kremlin Bicêtre , France.
Feriel J; a Department of Hematology , Centre Hospitalier Universitaire, Université Paris Sud 11 , Le Kremlin Bicêtre , France.
Sloma I; a Department of Hematology , Centre Hospitalier Universitaire, Université Paris Sud 11 , Le Kremlin Bicêtre , France.
Bennaceur-Griscelli A; b INSERM U935 , Villejuif , France.
Turhan AG; a Department of Hematology , Centre Hospitalier Universitaire, Université Paris Sud 11 , Le Kremlin Bicêtre , France.

Leuk Lymphoma ; 58(2): 473-474, 2017 02.

Article in En | MEDLINE | ID: mdl-27389710

Subject(s)

Antineoplastic Agents/adverse effects; Drug Hypersensitivity Syndrome/diagnosis; Drug Hypersensitivity Syndrome/etiology; Imatinib Mesylate/adverse effects; Leukemia, Myelogenous, Chronic, BCR-ABL Positive/complications; Protein Kinase Inhibitors/adverse effects; Antineoplastic Agents/therapeutic use; Blood Cell Count; Drug Substitution; Fusion Proteins, bcr-abl/genetics; Humans; Imatinib Mesylate/therapeutic use; Leukemia, Myelogenous, Chronic, BCR-ABL Positive/diagnosis; Leukemia, Myelogenous, Chronic, BCR-ABL Positive/drug therapy; Leukemia, Myelogenous, Chronic, BCR-ABL Positive/genetics; Male; Middle Aged; Protein Kinase Inhibitors/therapeutic use; Skin/pathology; Treatment Outcome

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Protein Kinase Inhibitors / Drug Hypersensitivity Syndrome / Imatinib Mesylate / Antineoplastic Agents Type of study: Diagnostic_studies Limits: Humans / Male / Middle aged Language: En Journal: Leuk Lymphoma Journal subject: HEMATOLOGIA / NEOPLASIAS Year: 2017 Document type: Article Affiliation country: France

Search on Google

Add to My VHL

XML

PubMed Links